Crossmark Global Holdings’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,352
| Closed | -$258K | – | 1332 |
|
2023
Q4 | $258K | Sell |
2,352
-229
| -9% | -$25.1K | 0.01% | 1143 |
|
2023
Q3 | $262K | Sell |
2,581
-14
| -0.5% | -$1.42K | 0.01% | 1078 |
|
2023
Q2 | $308K | Sell |
2,595
-459
| -15% | -$54.5K | 0.01% | 1058 |
|
2023
Q1 | $317K | Buy |
3,054
+490
| +19% | +$50.9K | 0.01% | 1021 |
|
2022
Q4 | $227K | Sell |
2,564
-186
| -7% | -$16.5K | 0.01% | 1132 |
|
2022
Q3 | $221K | Buy |
2,750
+10
| +0.4% | +$804 | 0.01% | 1130 |
|
2022
Q2 | $263K | Sell |
2,740
-60
| -2% | -$5.76K | 0.01% | 1092 |
|
2022
Q1 | $416K | Buy |
2,800
+80
| +3% | +$11.9K | 0.01% | 988 |
|
2021
Q4 | $386K | Buy |
2,720
+220
| +9% | +$31.2K | 0.01% | 1022 |
|
2021
Q3 | $327K | Sell |
2,500
-80
| -3% | -$10.5K | 0.01% | 1125 |
|
2021
Q2 | $355K | Sell |
2,580
-100
| -4% | -$13.8K | 0.01% | 1096 |
|
2021
Q1 | $350K | Sell |
2,680
-110
| -4% | -$14.4K | 0.01% | 1094 |
|
2020
Q4 | $312K | Sell |
2,790
-1,370
| -33% | -$153K | 0.01% | 1065 |
|
2020
Q3 | $327K | Sell |
4,160
-220
| -5% | -$17.3K | 0.01% | 969 |
|
2020
Q2 | $315K | Buy |
4,380
+340
| +8% | +$24.5K | 0.01% | 976 |
|
2020
Q1 | $231K | Sell |
4,040
-40
| -1% | -$2.29K | 0.01% | 984 |
|
2019
Q4 | $456K | Sell |
4,080
-2,500
| -38% | -$279K | 0.01% | 848 |
|
2019
Q3 | $633K | Sell |
6,580
-160
| -2% | -$15.4K | 0.02% | 696 |
|
2019
Q2 | $577K | Sell |
6,740
-536
| -7% | -$45.9K | 0.02% | 755 |
|
2019
Q1 | $605K | Buy |
7,276
+270
| +4% | +$22.5K | 0.02% | 728 |
|
2018
Q4 | $450K | Buy |
7,006
+2,480
| +55% | +$159K | 0.01% | 808 |
|
2018
Q3 | $359K | Buy |
4,526
+190
| +4% | +$15.1K | 0.01% | 1190 |
|
2018
Q2 | $317K | Buy |
4,336
+100
| +2% | +$7.31K | 0.01% | 1264 |
|
2018
Q1 | $268K | Sell |
4,236
-1,016
| -19% | -$64.3K | 0.01% | 1345 |
|
2017
Q4 | $268K | Sell |
5,252
-104
| -2% | -$5.31K | 0.01% | 1434 |
|
2017
Q3 | $281K | Buy |
+5,356
| New | +$281K | 0.01% | 1360 |
|
2016
Q3 | $281K | Buy |
+5,356
| New | +$281K | 0.01% | 1360 |
|